Vivo Bio Tech Limited (VIVOBIOT) Share Price
BSE · Healthcare · Biotechnology · ISIN INE380K01017
Key metrics
- Market Cap
- ₹40 Cr
- P/E Ratio
- —
- EPS
- -1.48
- Book Value
- 41.98
- P/B Ratio
- 0.43
- ROE
- -1.83%
- ROCE
- 6.74%
- Debt / Equity
- 0.72
- Net Margin
- -3.2%
- Revenue Growth
- 14.27%
- Profit Growth
- -123.46%
- Dividend Yield
- —
- 52W High
- ₹41.50
- 52W Low
- ₹17.65
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Vivo Bio Tech Limited
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents' evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 65.79%
The full Vivo Bio Tech Limited analysis
Create a free account to open the complete VIVOBIOT deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.